Interstitial quinacrine activates a distinctive immune response effective for tumor immunotherapy

Surgery

Volumn 136, Issue 3, 2004, Pages 700-707

  Sotelo, Julio ^a   Guevara, Patricia ^a   Pineda, Benjamin ^a   Diaz, Claudia ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOATTRACTANT; COMPLEMENT COMPONENT C3; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MEPACRINE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; CELL INFILTRATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; IMMUNITY, NATURAL; IMMUNOTHERAPY; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-6; KILLER CELLS, NATURAL; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES; MALE; MODELS, ANIMAL; MUSCLES; NECROSIS; NEOPLASMS; QUINACRINE; RANTES; RATS; RATS, WISTAR;

EID: 4444275518     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.01.008     Document Type: Article

References (32)

1. Roth W., Weller M. Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives. Cell Mol Life Sci. 56:1999;481-506
2. Deiters U., Muhlradt P.F. Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1 alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice. Infect Immun. 67:1999;3390-3398
3. MacKie R.M., Stewart B., Brown S.M. Intralesional injection of herpes simplex virus 1716 in metastatic melanoma. Lancet. 357:2001;525-526
4. Yu J.S., Wheeler C.J., Zeltzer P.M., Ying H., Finger D.N., Lee P.K., et al. Vaccination of malignant glioma patients with peptid pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res. 61:2001;842-847
5. Bhatt R.V., Aparicio A., Laufe L.E., Parmley T., King T.M. Quinacrine-induced pathologic changes in the fallopian tube. Fertil Steril. 33:1980;666-667
6. Taylor S.A., Hooton N.S., McArthur A.M. Quinacrine in the management of malignant pleural effusion. Br J Surg. 64:1977;52-53
7. Sotelo J., Guevara P., Reyes S., Arrieta O. Interstitial quinacrine for elimination of abnormal tissue; therapy of experimental glioma. Surgery. 128:2000;439-446
8. Lantz C.H., Van Dyke K. Studies concerning the mechanism of action of antimalarial drugs. II. Inhibition of the incorporation of adenosine-5'- monophosphate-3 H into nucleic acids of erythrocyte-free malarial parasites. Biochem Pharmacol. 20:1971;1157-1166
9. Spriggs D.R., Sherman M.L., Imamura K., Mohri M., Rodriguez C., Robbins G., et al. Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res. 50:1990;1701-1707
10. Reyes S., Herrera L., Ostrosky P., Sotelo J. Quinacrine enhances carmustine therapy of experimental rat glioma. Neurosurgery. 49:2001;969-973
11. Briceño E, Reyes S, Sotelo J. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurgical Focus 2003;14:Article 3, 1-6, http://www.neurosurgery.org/focus/feb03/14-2-3.pdf).
12. Sotelo J. Could an aminoacridine interfere with the cellular mechanisms involved in the process of human immunodeficiency virus infection? Med Hypotheses. 47:1996;43-47
13. Hieu D.T., Tan T.T., Tan D.N., Nguyet P.T., Than P., Vinh D.Q. 31781 cases of non-surgical female sterilization with quinacrine pellets in Vietnam. Lancet. 342:1993;213-217
14. Marshall E., Howell A.H., Powles R., Hunter M.G., Edwards M., Wood L.M., et al. Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010. Eur J Cancer. 34:1998;1023-1029
15. Kunstfeld R., Lechleitner S., Wolff K., Petzelbauer P. MCP-1 and MIP-1alpha are most efficient in recruiting T cells into the skin in vivo. J Invest Dermatol. 111:1998;1040-1044
16. Mercer-Jones M.A., Shrotri M.S., Heinzelmann M., Peyton J.C., Cheadle W.G. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J Leukoc Biol. 65:1999;249-255
17. Siveke J.T., Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol. 160:1998;550-554
18. Andrian U.H., Mackay C.R. T-cell function and migration. N Engl J Med. 343:2000;1020-1034
19. Staruch M.J., Camacho R., Dumont F.J. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. Cell Immunol. 190:1998;121-131
20. Matsukawa A., Hogaboam C.M., Lukacs N.W., Kunkel S.L. Chemokines and innate immunity. Rev Immunogenetics. 2:2000;339-358
21. Biswas P., Delfanti F., Bernasconi S., Mengozzi M., Cota M., Polentarutti N., et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 91:1998;258-265
22. Barsig J., Flesch I.E., Kaufmann S.H. Macrophages and hepatocytic cells as chemokine producers in murine listeriosis. Immunobiology. 199:1998;87-104
23. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 340:1999;448-454
24. Rodenburg R.J., Brinkhuis R.F., Peek R., Westphal J.R., Van Den Hoogen F.H., van Venrooij W.J., et al. Expression of macrophage-derived chemokine (MDC) mRNA in macrophages is enhanced by interleukin-1beta, tumor necrosis factor alpha, and lipopolysaccharide. J Leukoc Biol. 63:1998;606-611
25. Wang H.Q., Smart R.C. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J Cell Sci. 12:1999;3497-3506
26. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci. 9:1999;10923-10930
27. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., Kunkel S.L. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect Immun. 5:1997;3847-3851
28. Sato Y., Ohshima T., Kondo T. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun. 265:1999;194-199
29. Burg N.D., Pillinger M.H. The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol. 99:2001;7-17
30. Riese J., Denzel C., Zowe M., Mehler C., Hohenberger W., Haupt W. Secretion of IL-6, monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha, and TNFalpha by cultured intact human peritoneum. Eur Surg Res. 31:1999;281-288
31. Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunol. 2:2001;293-299
32. Fischer B., Muller B., Fisch P., Kreutz W. An acidic microenvironment inhibits antitumoral non-major histocompatibility complex-restricted cytotoxicity: implications for cancer immunotherapy. J Immunother. 23:2000;196-207